CH629960A5 - Composition pharmaceutique. - Google Patents

Composition pharmaceutique. Download PDF

Info

Publication number
CH629960A5
CH629960A5 CH1620277A CH1620277A CH629960A5 CH 629960 A5 CH629960 A5 CH 629960A5 CH 1620277 A CH1620277 A CH 1620277A CH 1620277 A CH1620277 A CH 1620277A CH 629960 A5 CH629960 A5 CH 629960A5
Authority
CH
Switzerland
Prior art keywords
composition according
weight
pharmaceutically acceptable
acid
acceptable salt
Prior art date
Application number
CH1620277A
Other languages
English (en)
French (fr)
Inventor
John Mann
David Edward Hall
Thomas Samuel Campbell
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of CH629960A5 publication Critical patent/CH629960A5/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CH1620277A 1977-01-25 1978-01-01 Composition pharmaceutique. CH629960A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2872/77A GB1557082A (en) 1977-01-25 1977-01-25 Pharmaceutical mixture containing an antiinflammatory

Publications (1)

Publication Number Publication Date
CH629960A5 true CH629960A5 (fr) 1982-05-28

Family

ID=9747602

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1620277A CH629960A5 (fr) 1977-01-25 1978-01-01 Composition pharmaceutique.

Country Status (16)

Country Link
US (2) US4151292A (enExample)
JP (1) JPS5394038A (enExample)
AU (1) AU522148B2 (enExample)
BE (1) BE862310A (enExample)
CA (1) CA1099641A (enExample)
CH (1) CH629960A5 (enExample)
DE (1) DE2756802A1 (enExample)
DK (1) DK576077A (enExample)
FI (1) FI773882A7 (enExample)
FR (1) FR2377804A1 (enExample)
GB (1) GB1557082A (enExample)
IL (1) IL53693A (enExample)
LU (1) LU78775A1 (enExample)
NL (1) NL7800016A (enExample)
NO (1) NO774400L (enExample)
SE (1) SE7714692L (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1595220A (en) * 1977-12-23 1981-08-12 Fisons Ltd Tablets containing 1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane
HU185926B (en) * 1979-09-27 1985-04-28 Agostne Kahan Process for preparing water soluble derivatives of non-steroid antiinflammatory compositions and pharmaceutical compositins containing such derivatives
BG39424A1 (en) * 1984-03-09 1986-06-16 Iliev Method for dynamic balancing in mounted state of rotary machines symetric with regard to gravity centre
FR2613619B1 (fr) * 1987-04-07 1993-10-15 Recherche Informatique Pharmacie Medicaments, produits dietetiques ou produits d'hygiene sous forme de compositions pulverulentes obtenues par adsorption de principes actifs sur un sucre a dissolution rapide
US4743596A (en) * 1987-06-16 1988-05-10 Lapin Alfred R Anti-arthritic preparation
GB9824604D0 (en) * 1998-11-11 1999-01-06 Hewlett Healthcare Limited Treatment of allergic conditions
TWI241195B (en) * 2000-04-10 2005-10-11 Shionogi & Co Preventive agent for bile acidic diarrhea
KR101971218B1 (ko) * 2006-11-09 2019-08-27 오렉시젠 세러퓨틱스 인크. 신속하게 용해되는 중간층을 포함하는 층상의 약제학적 제형
US20080306506A1 (en) * 2007-06-11 2008-12-11 Leatherman Dennis A Self-inflating and deflating intragastric balloon implant device

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1144905A (en) * 1965-03-25 1969-03-12 Fisons Pharmaceuticals Ltd Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
FI773882A7 (fi) 1978-07-26
FR2377804A1 (fr) 1978-08-18
IL53693A (en) 1981-09-13
GB1557082A (en) 1979-12-05
AU3193977A (en) 1979-06-28
US4151292A (en) 1979-04-24
NO774400L (no) 1978-07-26
AU522148B2 (en) 1982-05-20
US4232012A (en) 1980-11-04
DK576077A (da) 1978-07-26
SE7714692L (sv) 1978-07-26
NL7800016A (nl) 1978-07-27
FR2377804B1 (enExample) 1980-10-31
LU78775A1 (enExample) 1978-07-11
DE2756802A1 (de) 1978-07-27
IL53693A0 (en) 1978-03-10
BE862310A (fr) 1978-06-23
JPS5394038A (en) 1978-08-17
CA1099641A (en) 1981-04-21

Similar Documents

Publication Publication Date Title
US4066756A (en) Therapeutic compositions of 1,3-bis(2-carboxychromon-5-yloxyl)propan-2-ol and aspirin or indomethacin
CA2618212C (fr) Association d'un agent hypnotique a duree d'action longue et d'un agent hypnotique a duree d'action courte et son application therapeutique
WO2009082459A2 (en) Anti-aging composition containing resveratrol and method of administration
LU82026A1 (fr) Preparation pharmaceutique comprenant un glycoside cardiaque ayant un revetement de polymere
FR2613619A1 (fr) Medicaments, produits dietetiques ou produits d'hygiene sous forme de compositions pulverulentes obtenues par adsorption de principes actifs sur un sucre a dissolution rapide
WO2008122190A1 (en) The composition comprising l-carnitine or derivatives thereof and its use
EA014707B1 (ru) Новая форма введения рацекадотрила
JPS635020A (ja) 制御放出性イブプロフエン製剤
RU2672573C2 (ru) Фармацевтический комбинированный состав капсулы, содержащий тадалафил и тамсулозин
US8093408B2 (en) Antidepressant oral pharmaceutical compositions
EP2731609A1 (en) Nicotinamide compositions and the therapeutic use thereof
CH629960A5 (fr) Composition pharmaceutique.
GB2170709A (en) Pharmaceutical compositions with analgesic properties and the preparation and use thereof
JPH0354926B2 (enExample)
FR2628971A1 (fr) Forme d'administration solide, a desagregation rapide, du diclofenac
RU2679652C1 (ru) Способ получения гранул с энтеросолюбильным покрытием, содержащих ингибитор протонного насоса, и фармацевтических композиций, состоящих из множества частиц и содержащих эти гранулы
BE897221A (fr) Produits a effet prolonge contenant du suloctidil
WO2008083561A1 (en) Oral pharmaceutical composition of glycyrrhizin or its salts and the preparation method thereof
HK1207563A1 (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
EP4358943A1 (en) Naltrexone for boosting the therapeutic utility of 5-ht receptor agonists
US3784683A (en) Tablet preparation
JP2022549833A (ja) 経口速放出性医薬組成物および減量治療の方法
FR2504390A1 (fr) Composition a base de potassium pour combler un deficit de l'organisme en cet element
RU2354378C1 (ru) Комбинированный противотуберкулезный препарат
EP4313155A1 (fr) Formulation par voie orale d'ivermectine et utilisations

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased